ASX - By Stock
|
ECS |
Re:
ECS Price Action
|
|
mattstambe
|
2.1K |
466K |
4 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
2.1K
|
466K
|
4
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Loan Facility
|
|
mattstambe
|
7 |
4.5K |
1 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
7
|
4.5K
|
1
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Epsilon Healthcare Rebranding
|
|
mattstambe
|
6 |
3.2K |
1 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
6
|
3.2K
|
1
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mattstambe
|
6 |
2.1K |
1 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
6
|
2.1K
|
1
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Results of Meeting
|
|
mattstambe
|
11 |
6.0K |
2 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
11
|
6.0K
|
2
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Proposed issue of securities - CAN
|
|
mattstambe
|
35 |
14K |
7 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
35
|
14K
|
7
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial
|
|
mattstambe
|
70 |
23K |
2 |
26/04/23 |
26/04/23 |
ASX - By Stock
|
70
|
23K
|
2
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Full Year Statutory Accounts
|
|
mattstambe
|
8 |
4.8K |
5 |
22/04/23 |
22/04/23 |
ASX - By Stock
|
8
|
4.8K
|
5
|
|
ASX - By Stock
|
AVE |
Re:
Avecho channel 7
|
|
mattstambe
|
41 |
8.9K |
1 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
41
|
8.9K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Avecho channel 7
|
|
mattstambe
|
41 |
8.9K |
3 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
41
|
8.9K
|
3
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Receipt of Shareholder Notice
|
|
mattstambe
|
50 |
14K |
0 |
13/04/23 |
13/04/23 |
ASX - By Stock
|
50
|
14K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Full Year Statutory Accounts
|
|
mattstambe
|
8 |
4.8K |
5 |
01/04/23 |
01/04/23 |
ASX - By Stock
|
8
|
4.8K
|
5
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Vitura Health joining S&P/ASX All Ordinaries Index
|
|
mattstambe
|
92 |
34K |
2 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
92
|
34K
|
2
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Partially Divest Animal Health Assets
|
|
mattstambe
|
24 |
13K |
8 |
12/03/23 |
12/03/23 |
ASX - By Stock
|
24
|
13K
|
8
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mattstambe
|
30 |
8.5K |
2 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
30
|
8.5K
|
2
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Quarterly Activities and Appendix 4C Cashflow Report
|
|
mattstambe
|
60 |
16K |
5 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
60
|
16K
|
5
|
|
ASX - By Stock
|
CAN |
Re:
Ann: S3 Trial update
|
|
mattstambe
|
73 |
23K |
2 |
29/01/23 |
29/01/23 |
ASX - By Stock
|
73
|
23K
|
2
|
|
ASX - By Stock
|
CAN |
Re:
Ann: S3 Trial update
|
|
mattstambe
|
73 |
23K |
4 |
29/01/23 |
29/01/23 |
ASX - By Stock
|
73
|
23K
|
4
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Changes to clinical operations
|
|
mattstambe
|
28 |
11K |
1 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
28
|
11K
|
1
|
|
ASX - By Stock
|
CAN |
Re:
Ann: S3 Trial update
|
|
mattstambe
|
73 |
23K |
3 |
21/01/23 |
21/01/23 |
ASX - By Stock
|
73
|
23K
|
3
|
|
ASX - By Stock
|
CAN |
Re:
Ann: S3 Trial update
|
|
mattstambe
|
73 |
23K |
4 |
21/01/23 |
21/01/23 |
ASX - By Stock
|
73
|
23K
|
4
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Changes to clinical operations
|
|
mattstambe
|
28 |
11K |
1 |
21/01/23 |
21/01/23 |
ASX - By Stock
|
28
|
11K
|
1
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Appointment of new CEO
|
|
mattstambe
|
9 |
4.7K |
1 |
18/01/23 |
18/01/23 |
ASX - By Stock
|
9
|
4.7K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Changes to clinical operations
|
|
mattstambe
|
28 |
11K |
4 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
28
|
11K
|
4
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Changes to clinical operations
|
|
mattstambe
|
28 |
11K |
2 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
28
|
11K
|
2
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: Resignation of Non-Executive Director
|
|
mattstambe
|
29 |
15K |
4 |
15/01/23 |
15/01/23 |
ASX - By Stock
|
29
|
15K
|
4
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Commencement of Phase II/III ASD Clinical Trial
|
|
mattstambe
|
9 |
3.2K |
0 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
9
|
3.2K
|
0
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Company Secretary Appointment/Resignation
|
|
mattstambe
|
4 |
2.8K |
3 |
29/12/22 |
29/12/22 |
ASX - By Stock
|
4
|
2.8K
|
3
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl Opens Rights Issue
|
|
mattstambe
|
2 |
1.2K |
2 |
24/12/22 |
24/12/22 |
ASX - By Stock
|
2
|
1.2K
|
2
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Commencement of Phase II/III ASD Clinical Trial
|
|
mattstambe
|
9 |
3.2K |
3 |
19/12/22 |
19/12/22 |
ASX - By Stock
|
9
|
3.2K
|
3
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Release of shares from voluntary escrow
|
|
mattstambe
|
6 |
3.0K |
3 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
6
|
3.0K
|
3
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Cleansing Statement
|
|
mattstambe
|
5 |
2.5K |
1 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
5
|
2.5K
|
1
|
|
ASX - By Stock
|
LGP |
Re:
Ann: Letter to Shareholders for Share Purchase Plan
|
|
mattstambe
|
8 |
4.9K |
4 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
8
|
4.9K
|
4
|
|
ASX - By Stock
|
LGP |
Re:
Ann: Letter to Shareholders for Share Purchase Plan
|
|
mattstambe
|
8 |
4.9K |
2 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
8
|
4.9K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
TPM + CBG in Arthritis
|
|
mattstambe
|
7 |
2.4K |
2 |
20/11/22 |
20/11/22 |
ASX - By Stock
|
7
|
2.4K
|
2
|
|
ASX - By Stock
|
VIT |
Re:
Bell Potter Ratings
|
|
mattstambe
|
45 |
19K |
2 |
20/11/22 |
20/11/22 |
ASX - By Stock
|
45
|
19K
|
2
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Business Update & Appendix 4C
|
|
mattstambe
|
11 |
4.1K |
1 |
19/11/22 |
19/11/22 |
ASX - By Stock
|
11
|
4.1K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Bell Potter Ratings
|
|
mattstambe
|
45 |
19K |
1 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
45
|
19K
|
1
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Cleansing Statement
|
|
mattstambe
|
5 |
2.5K |
1 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
5
|
2.5K
|
1
|
|
ASX - By Stock
|
VIT |
Re:
Bell Potter Ratings
|
|
mattstambe
|
45 |
19K |
3 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
45
|
19K
|
3
|
|
ASX - By Stock
|
VIT |
Re:
Bell Potter Ratings
|
|
mattstambe
|
45 |
19K |
2 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
45
|
19K
|
2
|
|
ASX - By Stock
|
VIT |
Re:
Bell Potter Ratings
|
|
mattstambe
|
45 |
19K |
6 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
45
|
19K
|
6
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Business Update & Appendix 4C
|
|
mattstambe
|
11 |
4.1K |
0 |
12/11/22 |
12/11/22 |
ASX - By Stock
|
11
|
4.1K
|
0
|
|
ASX - By Stock
|
VIT |
Re:
Bell Potter Ratings
|
|
mattstambe
|
45 |
19K |
3 |
12/11/22 |
12/11/22 |
ASX - By Stock
|
45
|
19K
|
3
|
|
ASX - By Stock
|
VIT |
Re:
Bell Potter Ratings
|
|
mattstambe
|
45 |
19K |
3 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
45
|
19K
|
3
|
|
ASX - By Stock
|
VIT |
Re:
Bell Potter Ratings
|
|
mattstambe
|
45 |
19K |
4 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
45
|
19K
|
4
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Director Resignation
|
|
mattstambe
|
7 |
2.6K |
7 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
7
|
2.6K
|
7
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: September 2022 Quarterly Activities and Cashflow Reports
|
|
mattstambe
|
14 |
7.0K |
4 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
14
|
7.0K
|
4
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Withdrawal of shareholder resolution
|
|
mattstambe
|
21 |
10K |
4 |
29/10/22 |
29/10/22 |
ASX - By Stock
|
21
|
10K
|
4
|
|
ASX - By Stock
|
EPN |
Re:
Ann: Becoming a substantial holder
|
|
mattstambe
|
3 |
2.1K |
4 |
11/10/22 |
11/10/22 |
ASX - By Stock
|
3
|
2.1K
|
4
|
|